Table 4.
Univariate and multivariate analyses to predict specimen Gleason score ≥ 7
| |
Univariate |
Multivariate |
||||
|---|---|---|---|---|---|---|
| P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | |
| FAS expression in biopsy cores (Low vs. High) |
< 0.0001 |
10.62 |
3.71-35.65 |
0.0012 |
34.15 |
3.42 - 1145.4 |
| Clinical T stage (cT1 vs. cT2 ≤) |
0.0293 |
3.66 |
1.13-16.49 |
0.4890 |
2.29 |
0.23 - 32.36 |
| Needle biopsy Gleason score ( ≤ 6 vs. 7≤) |
< 0.0001 |
72.45 |
17.84-499.7 |
< 0.0001 |
228.17 |
25.37 - 8358.31 |
| PSA (ng/ml) |
0.0174 |
1.09 |
1.01-1.19 |
0.0202 |
1.22 |
1.03 -1.57 |
| Positive core rate (%) (≤ 40% vs. 40% <) |
0.007 |
5.76 |
1.53-37.7 |
0.9106 |
1.14 |
0.10 - 10.95 |
| Total biopsy cores (≤ 8 vs. 8 <) | 0.4131 | 1.48 | 0.58-3.84 | 0.9423 | 1.08 | 0.14 - 8.42 |